Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Accumulated Expenses (2016 - 2017)

Bone Biologics (BBLG) has disclosed Accumulated Expenses for 2 consecutive years, with $191667.0 as the latest value for Q3 2017.

  • On a quarterly basis, Accumulated Expenses changed N/A to $191667.0 in Q3 2017 year-over-year; TTM through Sep 2017 was $191667.0, a N/A change, with the full-year FY2016 number at $11250.0, changed N/A from a year prior.
  • Accumulated Expenses was $191667.0 for Q3 2017 at Bone Biologics, up from $141667.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $191667.0 in Q3 2017 to a low of $901.0 in Q1 2016.